Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706784 · ClinicalTrials.gov registry record · Phase 1
Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00706784: Clinical Trial Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00706784 is a Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706784, a Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.
Interventions
- DRUG Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706784
The ClinicalTrials.gov registry entry for NCT00706784 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System is the first listed.
NCT00706784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706784 about?
NCT00706784 is a clinical study titled "Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study". This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.
What is the current status of trial NCT00706784?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00706784?
The interventions under investigation include: Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System (DRUG).
Who is sponsoring clinical trial NCT00706784?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.